Censo Biotechnologies Ltd is a stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. The company has the capabilities to generate induced pluripotent stem cells (iPSCs) from large cohorts of individuals and use the potential of these cells to create virtually any cell in the human body. By developing cell development of new targeted treatments for disease. Its major focus is the generation of novel data on drug efficacy and drug response variation for a given population. The company was founded in 2016 through the merger of Roslin Cellab and Roslin Cell Sciences and has facilities in both Edinburgh and Cambridge, UK.
We still offer comprehensive and professional training in tissue culture technology ranging from beginner level through to the scientist requiring either a refresher course or to expand their current knowledge into that of human pluripotent stem cell culture and research. We can also offer training to suit your specific needs, tailored to fit your stem cell research, or advice thorough consultation on how to establish tissue culture facilities within your research laboratory. For more details, these can be found within our Training section.